Hideaki Sugiyama

1.2k citations
11 papers · 966 indexed · h-index 10
Topics
T-cell and B-cell Immunology (5 papers)Psoriasis: Treatment and Pathogenesis (4 papers)Immune Cell Function and Interaction (4 papers)

In The Last Decade

Hideaki Sugiyama

11 papers receiving 943 citations

Peers

Hideaki Sugiyama
Comparison fields: 5 of 80
  • Immunology 750
  • Dermatology 291
  • Oncology 166
  • Molecular Biology 125
  • Physiology 106
Replace Giampiero Girolomoni with:
Giampiero Girolomoni Italy
Jan D. Haas Germany
Nina Oberle Germany
Katarzyna Grys United Kingdom
Rajia Bahri United Kingdom
Mark Mellett Switzerland
Mohit Kashyap United States
Elisabetta Agea Italy
Yi Fritz United States
Vadim Budagian Germany
Hideaki Sugiyama relative to Giampiero Girolomoni Italy Giampiero Girolomoni's profile →
Citations per field
00.5×1.5×2.3×
Giampiero Girolomoni · 1×
Citations per year

Countries citing papers authored by Hideaki Sugiyama

Since Specialization
Citations

This map shows the geographic impact of Hideaki Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Sugiyama more than expected).

Fields of papers citing papers by Hideaki Sugiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Sugiyama. The network helps show where Hideaki Sugiyama may publish in the future.

Co-authorship network of co-authors of Hideaki Sugiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Sugiyama. A scholar is included among the top collaborators of Hideaki Sugiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Sugiyama. Hideaki Sugiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 20
2 12
3 46
4 17
5 262
6 22
7 71
8 463
9 1
10 34
11 18

About Hideaki Sugiyama

Hideaki Sugiyama is a scholar working on Immunology, Dermatology and Physiology, having authored 11 papers that have together received 966 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Immunology (750 citations), Dermatology (291 citations) and Oncology (166 citations). Hideaki Sugiyama has collaborated with scholars based in Japan, United States and Hungary. Frequent co-authors include Thomas S. McCormick, Kevin D. Cooper, Edina Garaczi, Rolland Gyulai, Eiko Toichi, Shinji Shimada, Seth R. Stevens, Wendy A. Goodman, Alan D. Levine and Keiko Matsue. Their work appears in journals such as The Journal of Immunology, Clinical Immunology and Journal of Dermatological Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026